LinusBio's groundbreaking biochemical test marks the company's first international expansion, bringing early autism screening to Japanese families and healthcare providers
Partnership integrates ClearStrand-ASD™ with full-spectrum care to streamline autism diagnosis and early intervention
The new, groundbreaking test uses just a strand of hair and can help healthcare providers rule out autism as early as one month of age
Partnership will utilize ClearStrand-ASD — LinusBio’s first-in-class biochemical test that identifies a molecular signature predictive of autism in a strand of hair
First-ever diagnostic aid to provide biochemically measurable insights about autism as early as one month of age Data to be presented at the Metabolomics and Human Health Conference GRC
Take a proactive step in supporting your child’s development and well-being with ClearStrand-ASD.
